Not checkedNot checked for notices yet.
Research priorities for Long Covid: refined through an international multi-stakeholder forum
Gail Carson, Long Covid Forum Group
BMC Medicine · 2021
doi:10.1186/s12916-021-01947-0 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
BackgroundCoronavirus disease 2019 (COVID-19) can lead to a diverse range of clinical manifestations, ranging from an asymptomatic infection to an acute respiratory distress syndrome, and multiorgan failure with high mortality rates [1].It is established that SARS-CoV-2 not only infects the respiratory tract but that the ensuing viral replication and immune response also affects multiple organ systems, in addition to an acute systemic inflammatory response and in some cases accompanying tissue hypoxia and shock.While many who have been infected have uncomplicated recoveries, some have prolonged illness.Prolonged course of illness has been reported in adults and children and is affecting both those who were hospitalised with COVID-19 and those who were not [2][3][4][5][6][7].In December 2020 ISARIC (the International Severe Acute Respiratory and emerging Infection Consortium), the research funders group GloPID-R (The Global Research Collaboration for Infectious Disease Preparedness) and global group, Long Covid Support, jointly organised a 'Long Covid Forum' [8].This public forum aimed to gain a better understanding of 'Long Covid' and to define research priorities for funders and researchers to take forward. Emerging themes Global patient voicesA complex, multi-faceted condition involving a range of physical, cognitive, psychological and social implications was described by people living with Long Covid from around the world.There was a call for a systematic way to define cases and to build awareness of Long Covid in the medical community globally to ensure recognition.Themes of isolation, social stigma, inability to care for family and economic repercussions were heard repeatedly.Integration of multi-disciplinary, holistic care into health systems is needed, including understanding the scale of resources that need to be mobilised and how to ensure equity in access to care across the world.Specific questions emerged around whether anti-viral treatment, during acute infection, could prevent Long Covid and improve long-term outcomes.Pertinent questions about the need to understand the effect that vaccination may have on people living with Long Covid were raised. Overarching summary of knowledge of Long CovidAn analysis by a rapid living systematic review on Long Covid clinical characteristics [7] highlights the limited evidence base and heterogeneity in the design of published studies.Importantly, this work indicates little difference in the severity of symptoms between the studies in hospitalised and nonhospitalised groups.An analysis from the UKCDR
Abstract licence: CC BY-NC-ND
References7
- 3.
- 4.
- 5.
- 6.
3 more references, whose wording the paper’s licence keeps private.
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.